Literature DB >> 18991968

Quality of life in young people with cystic fibrosis: effects of hospitalization, age and gender, and differences in parent/child perceptions.

M Hegarty1, J Macdonald, P Watter, C Wilson.   

Abstract

BACKGROUND: The Cystic Fibrosis Questionnaire-Revised version (CFQ-R) was used to evaluate age/gender effects on quality of life (QOL) in Australian young people with cystic fibrosis (CF) who were inpatients/outpatients aged 6-18 years. Parent/child agreement was also examined.
METHOD: The CFQ-R was completed by 18 outpatients, and 15 inpatients at admission for an acute pulmonary exacerbation to a tertiary hospital, Brisbane, Australia, as well as by parents of those aged 6-13 years.
RESULTS: Inpatients scored significantly lower than outpatients for the CFQ-R domains 'emotional state', 'social', 'body image' and 'respiratory symptoms'. Young people aged 6-13 years scored significantly better than those aged 14-18 years for 'emotional state', 'body image' and 'treatment burden'. Women perceived less 'treatment burden' than did men. Young people aged 6-13 years perceived less 'treatment burden' than did their parents. A significant interaction occurred between child/parent report and gender for 'emotional state' and 'eating disturbances'.
CONCLUSION: The CFQ-R found differences between inpatients and outpatients and between younger and older paediatric patients with CF, and between parent and child perceptions of QOL.

Entities:  

Mesh:

Year:  2008        PMID: 18991968     DOI: 10.1111/j.1365-2214.2008.00900.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  13 in total

Review 1.  Developmental and psychosocial issues in cystic fibrosis.

Authors:  Michelle M Ernst; Mark C Johnson; Lori J Stark
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-04

2.  Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.

Authors:  Karine Chevreul; Morgane Michel; Karen Berg Brigham; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Márta Péntek; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Ulf Persson; Giovani Fattore
Journal:  Eur J Health Econ       Date:  2016-04-08

3.  Time Free From Hospitalization in Children and Adolescents With Cystic Fibrosis: Findings From FEV1, Lung Clearance Index and Peak Work Rate.

Authors:  Simone Gambazza; Alessandra Mariani; Anna Brivio; Federica Carta; Chiara Blardone; Saba Lisiero; Maria Russo; Carla Colombo
Journal:  Front Pediatr       Date:  2022-06-22       Impact factor: 3.569

4.  Health-related quality of life in children and adolescents with cystic fibrosis: convergent validity with parent-reports and objective measures of pulmonary health.

Authors:  Audrey Tluczek; Tara Becker; Adam Grieve; Anita Laxova; Michael J Rock; William M Gershan; Christopher G Green; Philip M Farrell
Journal:  J Dev Behav Pediatr       Date:  2013-05       Impact factor: 2.225

5.  Factors associated with changes in health-related quality of life in children with cystic fibrosis during 1-year follow-up.

Authors:  Marieke van Horck; Bjorn Winkens; Geertjan Wesseling; Karin de Winter-de Groot; Ilja de Vreede; Quirijn Jöbsis; Edward Dompeling
Journal:  Eur J Pediatr       Date:  2017-06-09       Impact factor: 3.183

6.  Daily spirometry in an acute exacerbation of adult cystic fibrosis patients.

Authors:  Michael J Stephen; Alex Long; Chad Bonsall; Jeffrey B Hoag; Smita Shah; Dorothy Bisberg; Douglas Holsclaw; Laurie Varlotta; Stan Fiel; Doantrang Du; Robert Zanni; Denis Hadjiliadis
Journal:  Chron Respir Dis       Date:  2017-11-28       Impact factor: 2.444

7.  Assessing and responding to stress related to pulmonary function testing in cystic fibrosis through quality improvement.

Authors:  Kelsey Nusbaum; Stephanie S Filigno; Julie Feldstein; Elizabeth Hente; Elizabeth Koch; Lisa Mullen; Jeanne Weiland; Thomas Boat; Christopher Siracusa
Journal:  Pediatr Pulmonol       Date:  2020-02-10

8.  Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.

Authors:  Bradley S Quon; David A Ngan; Pearce G Wilcox; S F Paul Man; Don D Sin
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

9.  Psychosocial distress and functioning of Greek youth with cystic fibrosis: a cross-sectional study.

Authors:  Konstantina Kostakou; George Giannakopoulos; Stavroula Diareme; Chara Tzavara; Stavros Doudounakis; Stelios Christogiorgos; Chryssa Bakoula; Gerasimos Kolaitis
Journal:  Biopsychosoc Med       Date:  2014-06-11

10.  Validity of the DISABKIDS®-Cystic Fibrosis Module for Brazilian children and adolescents.

Authors:  Danielle Maria de Souza Serio dos Santos; Keila Cristiane Deon; Monika Bullinger; Claudia Benedita dos Santos
Journal:  Rev Lat Am Enfermagem       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.